Browse > Article
http://dx.doi.org/10.4062/biomolther.2019.192

Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women  

Jee, Hye Jin (College of Pharmacy, Ajou University)
Shin, Wonseok (College of Pharmacy, Ajou University)
Jung, Ho Joong (College of Pharmacy, Ajou University)
Kim, Baekgyu (Graduate School of Global Pharmaceutical Industry and Clinical Pharmacy, Ajou University)
Lee, Bo Kyung (College of Pharmacy, Ajou University)
Jung, Yi-Sook (College of Pharmacy, Ajou University)
Publication Information
Biomolecules & Therapeutics / v.28, no.1, 2020 , pp. 58-73 More about this Journal
Abstract
Sleep is an essential physiological process, especially for proper brain function through the formation of new pathways and processing information and cognition. Therefore, when sleep is insufficient, this can result in pathophysiologic conditions. Sleep deficiency is a risk factor for various conditions, including dementia, diabetes, and obesity. Recent studies have shown that there are differences in the prevalence of sleep disorders between genders. Insomnia, the most common type of sleep disorder, has been reported to have a higher incidence in females than in males. However, sex/gender differences in other sleep disorder subtypes are not thoroughly understood. Currently, increasing evidence suggests that gender issues should be considered important when prescribing medicine. Therefore, an investigation of the gender-dependent differences in sleep disorders is required. In this review, we first describe sex/gender differences not only in the prevalence of sleep disorders by category but in the efficacy of sleep medications. In addition, we summarize sex/gender differences in the impact of sleep disorders on incident dementia. This may help understand gender-dependent pathogenesis of sleep disorders and develop therapeutic strategies in men and women.
Keywords
Sleep disorder; Therapeutics; Sex/gender differences; Dementia risk factor;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Fatani, A., Al-Rouqi, K., Al Towairky, J., Ahmed, A. E., Al-Jahdali, S., Ali, Y., Al-Shimemeri, A., Al-Harbi, A., Baharoon, S., Khan, M. and Al-Jahdali, H. (2015) Effect of age and gender in the prevalence of excessive daytime sleepiness among a sample of the Saudi population. J. Epidemiol. Glob. Health 5, S59-S66.   DOI
2 Fleetham, J. A. and Fleming, J. A. (2014) Parasomnias. CMAJ 186, E273-E280.   DOI
3 Foley, D., Monjan, A., Masaki, K., Ross, W., Havlik, R., White, L. and Launer, L. (2001) Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J. Am. Geriatr. Soc. 49, 1628-1632.   DOI
4 Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B. and Blazer, D. G. (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18, 425-432.   DOI
5 Gabbay, F. H. (2003) Variations in affect following amphetamine and placebo: markers of stimulant drug preference. Exp. Clin. Psychopharmacol. 11, 91-101.   DOI
6 Gehrman, P., Marler, M., Martin, J. L., Shochat, T., Corey-Bloom, J. and Ancoli-Israel, S. (2004) The timing of activity rhythms in patients with dementia is related to survival. J. Gerontol. A Biol. Sci. Med. Sci. 59, 1050-1055.   DOI
7 George, A. J. (2000) Central nervous system stimulants. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 14, 79-88.   DOI
8 Gjerstad, M. D., Alves, G., Wentzel-Larsen, T., Aarsland, D. and Larsen, J. P. (2006) Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 67, 853-858.   DOI
9 Golden, L. C. and Voskuhl, R. (2017) The importance of studying sex differences in disease: the example of multiple sclerosis. J. Neurosci. Res. 95, 633-643.   DOI
10 Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., Griffith, P. A., Friedland, R. P., Bachman, D. and Farrer, L. (2003) Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 60, 753-759.   DOI
11 Greenblatt, D. J., Harmatz, J. S. and Karim, A. (2007) Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. J. Clin. Pharmacol. 47, 485-496.   DOI
12 Greenblatt, D. J., Harmatz, J. S., von Moltke, L. L., Wright, C. E. and Shader, R. I. (2004) Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin. Pharmacol. Ther. 76, 467-479.   DOI
13 Gu, D., Sautter, J., Pipkin, R. and Zeng, Y. (2010) Sociodemographic and health correlates of sleep quality and duration among very old Chinese. Sleep 33, 601-610.
14 Hara, C., Lopes Rocha, F. and Lima-Costa, M. F. (2004) Prevalence of excessive daytime sleepiness and associated factors in a Brazilian community: the Bambui study. Sleep Med. 5, 31-36.   DOI
15 Guarnieri, B. (2019) Sleep disorders and cognitive alterations in women. Maturitas 126, 25-27.   DOI
16 Guo, T., Mao, G., Zhao, L., Xia, D. and Yang, L. (2014) Comparative pharmacokinetics of zolpidem tartrate in five ethnic populations of China. Acta Pharm. Sin. B 4, 146-150.   DOI
17 Guo, T., Zhao, L. S. and Xia, D. Y. (2010) Pharmacokinetic study of modafinil in relation to gender and ethnicity in healthy young Chinese volunteers. J. Pharm. Pharm. Sci. 13, 443-449.   DOI
18 Hayley, A. C., Williams, L. J., Kennedy, G. A., Berk, M., Brennan, S. L. and Pasco, J. A. (2014) Prevalence of excessive daytime sleepiness in a sample of the Australian adult population. Sleep Med. 15, 348-354.   DOI
19 Heaney, R. P. (2001) Factors influencing the measurement of bioavailability, taking calcium as a model. J. Nutr. 131, 1344S-1348S.   DOI
20 Herring, W. J., Connor, K. M., Snyder, E., Snavely, D. B., Zhang, Y., Hutzelmann, J., Matzura-Wolfe, D., Benca, R. M., Krystal, A. D., Walsh, J. K., Lines, C., Roth, T. and Michelson, D. (2017) Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data. Psychopharmacology (Berl.) 234, 1703-1711.   DOI
21 Hobson, D. E., Lang, A. E., Martin, W. R., Razmy, A., Rivest, J. and Fleming, J. (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287, 455-463.   DOI
22 Hutchinson, M. A., Smith, P. F. and Darlington, C. L. (1996) The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs. Prog. Neurobiol. 49, 73-97.   DOI
23 Hofman, M. A. and Swaab, D. F. (2006) Living by the clock: the circadian pacemaker in older people. Ageing Res. Rev. 5, 33-51.   DOI
24 Howell, M. J. (2012) Parasomnias: an updated review. Neurotherapeutics 9, 753-775.   DOI
25 Hung, C. M., Li, Y. C., Chen, H. J., Lu, K., Liang, C. L., Liliang, P. C., Tsai, Y. D. and Wang, K. W. (2018) Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study. BMC Psychiatry 18, 38.   DOI
26 Ihara, M., Tomimoto, H., Ishizu, K., Mukai, T., Yoshida, H., Sawamoto, N., Inoue, M., Doi, T., Hashikawa, K., Konishi, J., Shibasaki, H. and Fukuyama, H. (2004) Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 35, 942-947.   DOI
27 Innes, K. E., Flack, K. L., Selfe, T. K., Kandati, S. and Agarwal, P. (2013) Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden. J. Clin. Sleep Med. 9, 1065-1075.   DOI
28 Ip, M. S., Lam, B., Ng, M. M., Lam, W. K., Tsang, K. W. and Lam, K. S. (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med. 165, 670-676.   DOI
29 Iranzo, A., Santamaria, J. and Tolosa, E. (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 15, 405-419.   DOI
30 Kazaglis, L. and Bornemann, M. A. C. (2016) Classification of parasomnias. Curr. Sleep Medicine Rep. 2, 45-52.   DOI
31 Keitt, S. K., Fagan, T. F. and Marts, S. A. (2004) Understanding sex differences in environmental health: a thought leaders' roundtable. Environ. Health Perspect. 112, 604-609.   DOI
32 Khan, Z. and Trotti, L. M. (2015) Central disorders of hypersomnolence: focus on the narcolepsies and idiopathic hypersomnia. Chest 148, 262-273.   DOI
33 Kiley, J. P., Twery, M. J. and Gibbons, G. H. (2019) The National Center on Sleep Disorders Research-progress and promise. Sleep 42, zsz105.   DOI
34 Kim, H. I., Lim, H. and Moon, A. (2018) Sex differences in cancer: epidemiology, genetics and therapy. Biomol. Ther. (Seoul) 26, 335-342.   DOI
35 Kim, H. M., Gerlach, L. B., Van, T., Yosef, M., Conroy, D. A. and Zivin, K. (2019) Predictors of long-term and high-dose use of zolpidem in Veterans. J. Clin. Psychiatry 80, 18m12149.
36 Kim, J. M., Stewart, R., Kim, S. W., Yang, S. J., Shin, I. S. and Yoon, J. S. (2009) Insomnia, depression, and physical disorders in late life: a 2-year longitudinal community study in Koreans. Sleep 32, 1221-1228.   DOI
37 Allen, R. P. and Earley, C. J. (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19, 205-213.   DOI
38 Anderson, K. N. and Shneerson, J. M. (2009) Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J. Clin. Sleep Med. 5, 235-239.   DOI
39 Arnulf, I., Neutel, D., Herlin, B., Golmard, J. L., Leu-Semenescu, S., Cochen de Cock, V. and Vidailhet, M. (2015) Sleepiness in idiopathic REM sleep behavior disorder and parkinson disease. Sleep 38, 1529-1535.   DOI
40 Islam, M. M., Iqbal, U., Walther, B., Atique, S., Dubey, N. K., Nguyen, P. A., Poly, T. N., Masud, J. H., Li, Y. J. and Shabbir, S. A. (2016) Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 47, 181-191.   DOI
41 Jacobs, M. L., Dauvilliers, Y., St Louis, E. K., McCarter, S. J., Romenets, S. R., Pelletier, A., Cherif, M., Gagnon, J. F. and Postuma, R. B. (2016) Risk factor profile in Parkinson's disease subtype with REM sleep behavior disorder. J. Parkinsons Dis. 6, 231-237.   DOI
42 Jaussent, I., Bouyer, J., Ancelin, M. L., Berr, C., Foubert-Samier, A., Ritchie, K., Ohayon, M. M., Besset, A. and Dauvilliers, Y. (2012) Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep 35, 1201-1207.   DOI
43 Joo, S., Baik, I., Yi, H., Jung, K., Kim, J. and Shin, C. (2009) Prevalence of excessive daytime sleepiness and associated factors in the adult population of Korea. Sleep Med. 10, 182-188.   DOI
44 Joo, S., Shin, C., Kim, J., Yi, H., Ahn, Y., Park, M., Kim, J. and Lee, S. (2005) Prevalence and correlates of excessive daytime sleepiness in high school students in Korea. Psychiatry Clin. Neurosci. 59, 433-440.   DOI
45 Jordan, A. S., McSharry, D. G. and Malhotra, A. (2014) Adult obstructive sleep apnoea. Lancet 383, 736-747.   DOI
46 Ju, Y. E., Larson-Prior, L. and Duntley, S. (2011) Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 12, 278-283.   DOI
47 Kang, J. E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S. and Holtzman, D. M. (2009) Amyloidbeta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007.   DOI
48 Aurora, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Ramar, K., Kristo, D. A., Morgenthaler, T. I.; Standards of Practice Committee; American Academy of Sleep Medicine (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J. Clin. Sleep Med. 6, 85-95.   DOI
49 Aston-Jones, G. and Cohen, J. D. (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403-450.   DOI
50 Aurora, R. N., Kristo, D. A., Bista, S. R., Rowley, J. A., Zak, R. S., Casey, K. R., Lamm, C. I., Tracy, S. L., Rosenberg, R. S.; American Academy of Sleep Medicine (2012) The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 35, 1039-1062.
51 Becker, J. B., Arnold, A. P., Berkley, K. J., Blaustein, J. D., Eckel, L. A., Hampson, E., Herman, J. P., Marts, S., Sadee, W., Steiner, M., Taylor, J. and Young, E. (2005) Strategies and methods for research on sex differences in brain and behavior. Endocrinology 146, 1650-1673.   DOI
52 Benbir, G. and Guilleminault, C. (2006) Pramipexole: new use for an old drug-the potential use of pramipexole in the treatment of restless legs syndrome. Neuropsychiatr. Dis. Treat. 2, 393-405.   DOI
53 Benedict, C., Byberg, L., Cedernaes, J., Hogenkamp, P. S., Giedratis, V., Kilander, L., Lind, L., Lannfelt, L. and Schioth, H. B. (2015) Selfreported sleep disturbance is associated with Alzheimer's disease risk in men. Alzheimers Dement. 11, 1090-1097.   DOI
54 Bennett, T., Bray, D. and Neville, M. W. (2014) Suvorexant, a dual orexin receptor antagonist for the management of insomnia. P T 39, 264-266.
55 Buysse, D. J. (2013) Insomnia. JAMA 309, 706-716.   DOI
56 Borgen, L. A., Okerholm, R., Morrison, D. and Lai, A. (2003) The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects. J. Clin. Pharmacol. 43, 59-65.   DOI
57 Boutrel, B. and Koob, G. F. (2004) What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27, 1181-1194.   DOI
58 Breslau, N., Roth, T., Rosenthal, L. and Andreski, P. (1996) Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 39, 411-418.   DOI
59 Chait, L. D. (1993) Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav. Pharmacol. 4, 191-199.   DOI
60 Chait, L. D. (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology (Berl.) 113, 381-387.   DOI
61 Chang, W. P., Liu, M. E., Chang, W. C., Yang, A. C., Ku, Y. C., Pai, J. T., Huang, H. L. and Tsai, S. J. (2013) Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan. PLoS ONE 8, e78655.   DOI
62 Chaudhury, D., Wang, L. M. and Colwell, C. S. (2005) Circadian regulation of hippocampal long-term potentiation. J. Biol. Rhythms 20, 225-236.   DOI
63 Chen, L., Bell, J. S., Visvanathan, R., Hilmer, S. N., Emery, T., Robson, L., Hughes, J. M. and Tan, E. C. (2016) The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study. BMC Geriatr. 16, 196.   DOI
64 Bjurstrom, M. F. and Irwin, M. R. (2019) Perioperative pharmacological sleep-promotion and pain control: a systematic review. Pain Pract. 19, 552-569.   DOI
65 Berdyyeva, T., Otte, S., Aluisio, L., Ziv, Y., Burns, L. D., Dugovic, C., Yun, S., Ghosh, K. K., Schnitzer, M. J., Lovenberg, T. and Bonaventure, P. (2014) Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope. PLoS ONE 9, e112068.   DOI
66 Bixler, E. O., Vgontzas, A. N., Lin, H. M., Ten Have, T., Rein, J., Vela-Bueno, A. and Kales, A. (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. 163, 608-613.   DOI
67 Bixler, E. O., Vgontzas, A. N., Lin, H. M., Vela-Bueno, A. and Kales, A. (2002) Insomnia in central Pennsylvania. J. Psychosom. Res. 53, 589-592.   DOI
68 Bliwise, D. L. (1993) Sleep in normal aging and dementia. Sleep 16, 40-81.   DOI
69 Boeuf-Cazou, O., Bongue, B., Ansiau, D., Marquie, J. C. and Lapeyre-Mestre, M. (2011) Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur. J. Clin. Pharmacol. 67, 1045-1052.   DOI
70 Bokenberger, K., Strom, P., Dahl Aslan, A. K., Johansson, A. L., Gatz, M., Pedersen, N. L. and Akerstedt, T. (2017) Association between sleep characteristics and incident dementia accounting for baseline cognitive status: a prospective population-based study. J. Gerontol. A Biol. Sci. Med. Sci. 72, 134-139.   DOI
71 Bonakis, A., Howard, R. S., Ebrahim, I. O., Merritt, S. and Williams, A. (2009) REM sleep behaviour disorder (RBD) and its associations in young patients. Sleep Med. 10, 641-645.   DOI
72 Cricco, M., Simonsick, E. M. and Foley, D. J. (2001) The impact of insomnia on cognitive functioning in older adults. J. Am. Geriatr. Soc. 49, 1185-1189.   DOI
73 Chen, P. L., Lee, W. J., Sun, W. Z., Oyang, Y. J. and Fuh, J. L. (2012) Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS ONE 7, e49113.   DOI
74 Cheng, H. T., Lin, F. J., Erickson, S. R., Hong, J. L. and Wu, C. H. (2017) The association between the use of zolpidem and the risk of Alzheimer's disease among older people. J. Am. Geriatr. Soc. 65, 2488-2495.   DOI
75 Cordovilla-Guardia, S., Lardelli-Claret, P., Vilar-Lopez, R., Lopez-Espuela, F., Guerrero-Lopez, F. and Fernandez-Mondejar, E. (2019) The effect of central nervous system depressant, stimulant and hallucinogenic drugs on injury severity in patients admitted for trauma. Gac. Sanit. 33, 4-9.   DOI
76 Crowley, K. (2011) Sleep and sleep disorders in older adults. Neuropsychol. Rev. 21, 41-53.   DOI
77 Culebras, A. and Anwar, S. (2018) Sleep apnea is a risk factor for stroke and vascular dementia. Curr. Neurol. Neurosci. Rep. 18, 53.   DOI
78 Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., Sanchez, R., Rios, C. D. and Ronda, J. M. (1992) Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 340, 933-936.   DOI
79 Dagan, Y. (2002) Circadian rhythm sleep disorders (CRSD). Sleep Med. Rev. 6, 45-55.   DOI
80 de Almondes, K. M., Costa, M. V., Malloy-Diniz, L. F. and Diniz, B. S. (2016) Insomnia and risk of dementia in older adults: systematic review and meta-analysis. J. Psychiatr. Res. 77, 109-115.   DOI
81 Earley, C. J. and Silber, M. H. (2010) Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 11, 807-815.   DOI
82 de Gage, S. B., Begaud, B., Bazin, F., Verdoux, H., Dartigues, J. F., Peres, K., Kurth, T. and Pariente, A. (2012) Benzodiazepine use and risk of dementia: prospective population based study. BMJ 345, e6231.   DOI
83 Diekelmann, S. and Born, J. (2010) The memory function of sleep. Nat. Rev. Neurosci. 11, 114-126.   DOI
84 Duran, J., Esnaola, S., Rubio, R. and Iztueta, A. (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med. 163, 685-689.   DOI
85 Elwood, P. C., Bayer, A. J., Fish, M., Pickering, J., Mitchell, C. and Gallacher, J. E. (2011) Sleep disturbance and daytime sleepiness predict vascular dementia. J. Epidemiol. Community Health 65, 820-824.   DOI
86 Erman, M., Seiden, D., Zammit, G., Sainati, S. and Zhang, J. (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med. 7, 17-24.   DOI
87 Evans, S. M., Haney, M., Fischman, M. W. and Foltin, R. W. (1999) Limited sex differences in response to “binge” smoked cocaine use in humans. Neuropsychopharmacology 21, 445-454.   DOI
88 Fantini, M. L., Postuma, R. B., Montplaisir, J. and Ferini-Strambi, L. (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res. Bull. 70, 386-390.   DOI
89 Dauvilliers, Y. and Buguet, A. (2005) Hypersomnia. Dialogues Clin. Neurosci. 7, 347-356.   DOI
90 Krueger, J. M., Frank, M. G., Wisor, J. P. and Roy, S. (2016) Sleep function: toward elucidating an enigma. Sleep Med. Rev. 28, 46-54.   DOI
91 Kushida, C. A., Littner, M. R., Hirshkowitz, M., Morgenthaler, T. I., Alessi, C. A., Bailey, D., Boehlecke, B., Brown, T. M., Coleman, J., Jr., Friedman, L., Kapen, S., Kapur, V. K., Kramer, M., Lee-Chiong, T., Owens, J., Pancer, J. P., Swick, T. J. and Wise, M. S.; American Academy of Sleep Medicine (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29, 375-380.   DOI
92 Lanctot, K. L., Herrmann, N., Mazzotta, P., Khan, L. R. and Ingber, N. (2004) GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can. J. Psychiatry 49, 439-453.   DOI
93 Sharma, M. K., Kainth, S., Kumar, S., Bhardwaj, A., Agarwal, H. K., Maiwall, R., Jamwal, K. D., Shasthry, S. M., Jindal, A., Choudhary, A., Anand, L., Dhamija, R. M., Kumar, G., Sharma, B. C. and Sarin, S. K. (2019) Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: a randomized, placebo-controlled trial. Clin. Mol. Hepatol. 25, 199-209.   DOI
94 Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N. and Heald, J. L. (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 13, 307-349.   DOI
95 Satlin, A., Volicer, L., Stopa, E. G. and Harper, D. (1995) Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 16, 765-771.   DOI
96 Schenck, C. H., Bundlie, S. R. and Mahowald, M. W. (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46, 388-393.   DOI
97 Shi, L., Chen, S. J., Ma, M. Y., Bao, Y. P., Han, Y., Wang, Y. M., Shi, J., Vitiello, M. V. and Lu, L. (2018) Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med. Rev. 40, 4-16.   DOI
98 Shih, H. I., Lin, C. C., Tu, Y. F., Chang, C. M., Hsu, H. C., Chi, C. H. and Kao, C. H. (2015) An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore) 94, e809.   DOI
99 Silber, M. H. (2013) Sleep-related movement disorders. Continuum (Minneap. Minn.) 19, 170-184.   DOI
100 Shimohama, S., Taniguchi, T., Fujiwara, M. and Kameyama, M. (1988) Changes in benzodiazepine receptors in Alzheimer-type dementia. Ann. Neurol. 23, 404-406.   DOI
101 Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. and Badr, S. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230-1235.   DOI
102 Wing, Y. K., Lam, S. P., Zhang, J., Leung, E., Ho, C. L., Chen, S., Cheung, M. K., Li, S. X., Chan, J. W., Mok, V., Tsoh, J., Chan, A. and Ho, C. K. (2015) Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. Neurology 84, 516-522.   DOI
103 Wing, Y. K., Li, S. X., Mok, V., Lam, S. P., Tsoh, J., Chan, A., Yu, M. W., Lau, C. Y., Zhang, J. and Ho, C. K. (2012) Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 83, 470-472.   DOI
104 Xie, Z., Chen, F., Li, W. A., Geng, X., Li, C., Meng, X., Feng, Y., Liu, W. and Yu, F. (2017) A review of sleep disorders and melatonin. Neurol. Res. 39, 559-565.   DOI
105 Yaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S. and Stone, K. L. (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306, 613-619.
106 Yayeh, T., Leem, Y. H., Kim, K. M., Jung, J. C., Schwarz, J., Oh, K. W. and Oh, S. (2018) Administration of alphas1-casein hydrolysate increases sleep and modulates GABAA receptor subunit expression. Biomol. Ther. (Seoul) 26, 268-273.   DOI
107 Young, T. and Peppard, P. (2000) Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 23, S122-S126.
108 Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J. and Roth, T. (2007) Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J. Clin. Sleep Med. 3, 495-504.   DOI
109 Zhou, J., Zhang, J., Lam, S. P., Chan, J. W., Mok, V., Chan, A., Li, S. X., Liu, Y., Tang, X., Yung, W. H. and Wing, Y. K. (2017) Excessive daytime sleepiness predicts neurodegeneration in idiopathic REM sleep behavior disorder. Sleep 40, doi: 10.1093/sleep/zsx041.
110 Zucker, I. and Beery, A. K. (2010) Males still dominate animal studies. Nature 465, 690.   DOI
111 Spira, A. P., Gamaldo, A. A., An, Y., Wu, M. N., Simonsick, E. M., Bilgel, M., Zhou, Y., Wong, D. F., Ferrucci, L. and Resnick, S. M. (2013) Self-reported sleep and beta-amyloid deposition in communitydwelling older adults. JAMA Neurol. 70, 1537-1543.   DOI
112 Silvia, R., Mor, M., Bedini, A., Spadoni, G. and Tarzia, G. (2008) Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. Curr. Top. Med. Chem. 8, 954-968.   DOI
113 Singareddy, R., Vgontzas, A. N., Fernandez-Mendoza, J., Liao, D., Calhoun, S., Shaffer, M. L. and Bixler, E. O. (2012) Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 13, 346-353.   DOI
114 Singer, H. S., Mink, J. W., Gilbert, D. L. and Jankovic, J. (2016) Chapter 19-Movements that occur in sleep. In Movement Disorders in Childhood (2nd ed.) (H. S. Singer, J. W. Mink, D. L. Gilbert and J. Jankovic, Eds.), pp. 427-451. Academic Press, Boston.
115 Susic, V. (2007) Normal sleep. Glas-Srpska Akademija Nauka I Umetnosti 49, 1-6.
116 Tannenbaum, C., Greaves, L. and Graham, I. D. (2016) Why sex and gender matter in implementation research. BMC Med. Res. Methodol. 16, 145.   DOI
117 Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J. and Carnahan, R. (2012) A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 29, 639-658.   DOI
118 Tranah, G. J., Blackwell, T., Stone, K. L., Ancoli-Israel, S., Paudel, M. L., Ensrud, K. E., Cauley, J. A., Redline, S., Hillier, T. A., Cummings, S. R. and Yaffe, K.; SOF Research Group (2011) Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 70, 722-732.   DOI
119 Tholfsen, L. K., Larsen, J. P., Schulz, J., Tysnes, O. B. and Gjerstad, M. D. (2015) Development of excessive daytime sleepiness in early Parkinson disease. Neurology 85, 162-168.   DOI
120 Thorpy, M. J. (2012) Classification of sleep disorders. Neurotherapeutics 9, 687-701.   DOI
121 Tsuno, N., Jaussent, I., Dauvilliers, Y., Touchon, J., Ritchie, K. and Besset, A. (2007) Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J. Sleep Res. 16, 364-371.   DOI
122 Vansickel, A. R., Stoops, W. W. and Rush, C. R. (2010) Human sex differences in d-amphetamine self-administration. Addiction 105, 727-731.   DOI
123 Wang, J. and Huang, Y. (2007) Pharmacogenomics of sex difference in chemotherapeutic toxicity. Curr. Drug Discov. Technol. 4, 59-68.   DOI
124 Wadworth, A. N. and McTavish, D. (1993) Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 3, 441-459.   DOI
125 Wagner, J. and Wagner, M. L. (2000) Non-benzodiazepines for the treatment of insomnia. Sleep Med. Rev. 4, 551-581.   DOI
126 Wan, H., Warburton, E. C., Zhu, X. O., Koder, T. J., Park, Y., Aggleton, J. P., Cho, K., Bashir, Z. I. and Brown, M. W. (2004) Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory. Eur. J. Neurosci. 20, 2214-2224.   DOI
127 Wing, Y. K., Lam, S. P., Li, S. X., Yu, M. W., Fong, S. Y., Tsoh, J. M., Ho, C. K. and Lam, V. K. (2008) REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J. Neurol. Neurosurg. Psychiatry 79, 1415-1416.   DOI
128 Leufkens, T. R. and Vermeeren, A. (2014) Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies. Clin. Ther. 36, 141-150.   DOI
129 Lee-Iannotti, J. K. and Parish, J. M. (2016) Suvorexant: a promising, novel treatment for insomnia. Neuropsychiatr Dis. Treat. 12, 491-495.
130 Lee, J., Jung, S. J., Choi, J. W., Shin, A. and Lee, Y. J. (2018) Use of sedative-hypnotics and the risk of Alzheimer’s dementia: a retrospective cohort study. PLoS ONE 13, e0204413.   DOI
131 Lin, C. C., Chou, C. H., Fan, Y. M., Yin, J. H., Chung, C. H., Chien, W. C., Sung, Y. F., Tsai, C. K., Lin, G. Y., Lin, Y. K. and Lee, J. T. (2015) Increased risk of dementia among sleep-related movement disorders: a population-based longitudinal study in Taiwan. Medicine (Baltimore) 94, e2331.   DOI
132 Lopes Da Silva, F. H. and Storm Van Leeuwen, W. (1977) The cortical source of the alpha rhythm. Neurosci. Lett. 6, 237-241.   DOI
133 Martinelli, P., Contin, M., Scaglione, C., Riva, R., Albani, F. and Baruzzi, A. (2003) Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? Neurol. Sci. 24, 192-193.   DOI
134 Lumeng, J. C. and Chervin, R. D. (2008) Epidemiology of pediatric obstructive sleep apnea. Proc. Am. Thorac. Soc. 5, 242-252.   DOI
135 Macey, P. M., Haris, N., Kumar, R., Thomas, M. A., Woo, M. A. and Harper, R. M. (2018) Obstructive sleep apnea and cortical thickness in females and males. PLoS ONE 13, e0193854.   DOI
136 Mahlknecht, P., Iranzo, A., Hogl, B., Frauscher, B., Muller, C., Santamaria, J., Tolosa, E., Serradell, M., Mitterling, T., Gschliesser, V., Goebel, G., Brugger, F., Scherfler, C., Poewe, W. and Seppi, K.; Sleep Innsbruck Barcelona Group (2015) Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 84, 654-658.   DOI
137 Mannucci, C., Pichini, S., Spagnolo, E. V., Calapai, F., Gangemi, S., Navarra, M. and Calapai, G. (2018) Sodium oxybate therapy for alcohol withdrawal syndrome and keeping of alcohol abstinence. Curr. Drug Metab. 19, 1056-1064.   DOI
138 Marion, M. H., Qurashi, M., Marshall, G. and Foster, O. (2008) Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? J. Neurol. 255, 192-196.   DOI
139 Molano, J., Boeve, B., Ferman, T., Smith, G., Parisi, J., Dickson, D., Knopman, D., Graff-Radford, N., Geda, Y., Lucas, J., Kantarci, K., Shiung, M., Jack, C., Silber, M., Pankratz, V. S. and Petersen, R. (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133, 540-556.   DOI
140 Moreira, F. A., Jupp, B., Belin, D. and Dalley, J. W. (2015) Endocannabinoids and striatal function: implications for addiction-related behaviours. Behav. Pharmacol. 26, 59-72.   DOI
141 Oginska, H., Pokorski, J. and Oginski, A. (1993) Gender, ageing, and shiftwork intolerance. Ergonomics 36, 161-168.   DOI
142 Paine, S. J., Fink, J., Gander, P. H. and Warman, G. R. (2014) Identifying advanced and delayed sleep phase disorders in the general population: a national survey of New Zealand adults. Chronobiol. Int. 31, 627-636.   DOI
143 Morgenthaler, T. I., Kapur, V. K., Brown, T., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Jr., Friedman, L., Maganti, R., Owens, J., Pancer, J. and Zak, R.; Standards of Practice Committee of the American Academy of Sleep Medicine (2007) Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 30, 1705-1711.   DOI
144 Morphy, H., Dunn, K. M., Lewis, M., Boardman, H. F. and Croft, P. R. (2007) Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30, 274-280.
145 Neubauer, D. N. (2008) A review of ramelteon in the treatment of sleep disorders. Neuropsychiatr. Dis. Treat. 4, 69-79.   DOI
146 Nomura, T., Inoue, Y., Kagimura, T. and Nakashima, K. (2013) Clinical significance of REM sleep behavior disorder in Parkinson's disease. Sleep Med. 14, 131-135.   DOI
147 Ohayon, M. M., Lemoine, P., Arnaud-Briant, V. and Dreyfus, M. (2002) Prevalence and consequences of sleep disorders in a shift worker population. J. Psychosom. Res. 53, 577-583.   DOI
148 Ohayon, M. M., O'Hara, R. and Vitiello, M. V. (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med. Rev. 16, 283-295.   DOI
149 Ohayon, M. M. and Roth, T. (2002) Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J. Psychosom. Res. 53, 547-554.   DOI
150 Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R. and Harrod, C. G. (2019) Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 15, 335-343.   DOI
151 Paudel, M. L., Taylor, B. C., Ancoli-Israel, S., Blackwell, T., Stone, K. L., Tranah, G., Redline, S., Cummings, S. R. and Ensrud, K. E.; Osteoporotic Fractures in Men (MrOS) Study (2010) Rest/activity rhythms and mortality rates in older men: MrOS Sleep Study. Chronobiol. Int. 27, 363-377.   DOI
152 Pase, M. P., Himali, J. J., Grima, N. A., Beiser, A. S., Satizabal, C. L., Aparicio, H. J., Thomas, R. J., Gottlieb, D. J., Auerbach, S. H. and Seshadri, S. (2017) Sleep architecture and the risk of incident dementia in the community. Neurology 89, 1244-1250.   DOI
153 Pakes, G. E., Brogden, R. N., Heel, R. C., Speight, T. M. and Avery, G. S. (1981) Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22, 81-110.   DOI
154 Pallesen, S., Nordhus, I. H., Omvik, S., Sivertsen, B., Tell, G. S. and Bjorvatn, B. (2007) Prevalence and risk factors of subjective sleepiness in the general adult population. Sleep 30, 619-624.   DOI
155 Pandi-Perumal, S. R., Trakht, I., Srinivasan, V., Spence, D. W., Maestroni, G. J., Zisapel, N. and Cardinali, D. P. (2008) Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 85, 335-353.   DOI
156 Pat McAndrews, M., Weiss, R. T., Sandor, P., Taylor, A., Carlen, P. L. and Shapiro, C. M. (2003) Cognitive effects of long-term benzodiazepine use in older adults. Hum. Psychopharmacol. 18, 51-57.   DOI
157 Paterniti, S., Dufouil, C., Bisserbe, J. C. and Alperovitch, A. (1999) Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol. Med. 29, 421-428.   DOI
158 Postuma, R. B., Gagnon, J. F., Bertrand, J. A., Genier Marchand, D. and Montplaisir, J. Y. (2015b) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84, 1104-1113.   DOI
159 Pigeon, W. R. and Yurcheshen, M. (2009) Behavioral sleep medicine interventions for Restless Legs Syndrome and Periodic Limb Movement Disorder. Sleep Med. Clin. 4, 487-494.   DOI
160 Postuma, R. B., Adler, C. H., Dugger, B. N., Hentz, J. G., Shill, H. A., Driver-Dunckley, E., Sabbagh, M. N., Jacobson, S. A., Belden, C. M., Sue, L. I., Serrano, G. and Beach, T. G. (2015a) REM sleep behavior disorder and neuropathology in Parkinson's disease. Mov. Disord. 30, 1413-1417.   DOI
161 Postuma, R. B., Montplaisir, J., Lanfranchi, P., Blais, H., Rompre, S., Colombo, R. and Gagnon, J. F. (2011) Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder. Mov. Disord. 26, 1529-1533.   DOI
162 Punjabi, N. M., Shahar, E., Redline, S., Gottlieb, D. J., Givelber, R. and Resnick, H. E.; Sleep Heart Health Study Investigators (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160, 521-530.   DOI
163 Rangel-Barajas, C., Coronel, I. and Floran, B. (2015) Dopamine receptors and neurodegeneration. Aging Dis. 6, 349-368.   DOI
164 Rezvani, M., Zamani, B. and Fereshtehnejad, S. M. (2013) Factors affecting the efficacy of pramipexole in patients with restless legs syndrome. Acta Med. Iran. 51, 377-385.
165 Romenets, S. R., Gagnon, J. F., Latreille, V., Panniset, M., Chouinard, S., Montplaisir, J. and Postuma, R. B. (2012) Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov. Disord. 27, 996-1003.   DOI
166 Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W. and Hla, K. M. (2013) Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 177, 1006-1014.   DOI
167 Phillips, B. and Mannino, D. (2005) Correlates of sleep complaints in adults: the ARIC study. J. Clin. Sleep Med. 1, 277-283.   DOI
168 Rissman, R. A., De Blas, A. L. and Armstrong, D. M. (2007) GABA(A) receptors in aging and Alzheimer's disease. J. Neurochem. 103, 1285-1292.   DOI
169 Roman, G. C. (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258, 1782-1788.   DOI
170 Romeijn, N., Raymann, R. J., Most, E., Te Lindert, B., Van Der Meijden, W. P., Fronczek, R., Gomez-Herrero, G. and Van Someren, E. J. (2012) Sleep, vigilance, and thermosensitivity. Pflugers Arch. 463, 169-176.   DOI
171 Saias, T. and Gallarda, T. (2008) Aggressive reactions under benzodiazepines: a review of the literature. Encephale 34, 330-336.   DOI
172 Sack, R. L., Auckley, D., Auger, R. R., Carskadon, M. A., Wright, K. P., Jr., Vitiello, M. V. and Zhdanova, I. V.; American Academy of Sleep Medicine (2007) Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30, 1460-1483.   DOI
173 Sancar, F., Ericksen, S. S., Kucken, A. M., Teissere, J. A. and Czajkowski, C. (2007) Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Mol. Pharmacol. 71, 38-46.   DOI
174 Sateia, M. J. (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146, 1387-1394.   DOI
175 Rhyne, D. N. and Anderson, S. L. (2015) Suvorexant in insomnia: efficacy, safety and place in therapy. Ther. Adv. Drug Saf. 6, 189-195.   DOI